These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 11717598)

  • 21. Efficacy and safety of minimal dose (< or =1,000 units) unfractionated heparin with abciximab in percutaneous coronary intervention.
    Denardo SJ; Davis KE; Reid PR; Tcheng JE
    Am J Cardiol; 2003 Jan; 91(1):1-5. PubMed ID: 12505562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One-year clinical outcomes with abciximab vs. placebo in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention after pre-treatment with clopidogrel: results of the ISAR-REACT 2 randomized trial.
    Ndrepepa G; Kastrati A; Mehilli J; Neumann FJ; ten Berg J; Bruskina O; Dotzer F; Seyfarth M; Pache J; Dirschinger J; Berger PB; Schömig A
    Eur Heart J; 2008 Feb; 29(4):455-61. PubMed ID: 18158289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-ambulance abciximab administration in STEMI patients prior to primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure: results from the Leiden MISSION! acute myocardial infarction treatment optimization program.
    Hassan AK; Liem SS; van der Kley F; Bergheanu SC; Wolterbeek R; Bosch J; Bootsma M; Zeppenfeld K; van der Laarse A; Atsma DE; Jukema JW; Schalij MJ
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):335-43. PubMed ID: 19642182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions.
    Abdelmeguid AE; Topol EJ; Whitlow PL; Sapp SK; Ellis SG
    Circulation; 1996 Oct; 94(7):1528-36. PubMed ID: 8840840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One year outcomes with abciximab vs. placebo during percutaneous coronary intervention after pre-treatment with clopidogrel.
    Schömig A; Schmitt C; Dibra A; Mehilli J; Volmer C; Schühlen H; Dirschinger J; Dotzer F; ten Berg JM; Neumann FJ; Berger PB; Kastrati A;
    Eur Heart J; 2005 Jul; 26(14):1379-84. PubMed ID: 15734767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
    Lansky AJ; Pietras C; Costa RA; Tsuchiya Y; Brodie BR; Cox DA; Aymong ED; Stuckey TD; Garcia E; Tcheng JE; Mehran R; Negoita M; Fahy M; Cristea E; Turco M; Leon MB; Grines CL; Stone GW
    Circulation; 2005 Apr; 111(13):1611-8. PubMed ID: 15811868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting.
    Kugelmass AD; Cohen DJ; Moscucci M; Piana RN; Senerchia C; Kuntz RE; Baim DS
    Am J Cardiol; 1994 Oct; 74(8):748-54. PubMed ID: 7942542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nicardipine and adenosine "flush cocktail" to prevent no-reflow during rotational atherectomy.
    Fischell TA; Haller S; Pulukurthy S; Virk IS
    Cardiovasc Revasc Med; 2008; 9(4):224-8. PubMed ID: 18928946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention.
    Kini A; Marmur JD; Kini S; Dangas G; Cocke TP; Wallenstein S; Brown E; Ambrose JA; Sharma SK
    J Am Coll Cardiol; 1999 Sep; 34(3):663-71. PubMed ID: 10483945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of coronary microembolization by Doppler ultrasound in patients with stable angina pectoris during percutaneous coronary interventions under an adjunctive antithrombotic therapy with abciximab: design and rationale of the High Intensity Transient Signals ReoPro (HITS-RP) study.
    Kretzschmar D; Jung C; Otto S; Utschig S; Hartmann M; Lehmann T; Yilmaz A; Pörner TC; Figulla HR; Ferrari M
    Cardiovasc Ultrasound; 2012 May; 10():21. PubMed ID: 22613136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of periprocedural creatine kinase-myocardial band elevation complicating elective percutaneous coronary intervention.
    Cai Q; Skelding KA; Armstrong AT; Desai D; Wood GC; Blankenship JC
    Am J Cardiol; 2007 Mar; 99(5):616-20. PubMed ID: 17317359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relation of Post-Coronary Artery Bypass Graft Creatine Kinase-MB Elevations and New Q Waves With Long-Term Cardiovascular Death in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease.
    Domanski M; Farkouh ME; Zak V; French J; Alexander JH; Bochenek A; Hamon M; Mahaffey K; Puskas J; Smith P; Shrader P; Fuster V
    Am J Cardiol; 2016 Dec; 118(11):1655-1660. PubMed ID: 27816118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of coronary rotational atherectomy related complications].
    Luo JF; Dong HJ; Li G; Huang WH; Liu Y; Yu DQ; Tan N; Zhou YL; Chen JY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jun; 41(6):470-3. PubMed ID: 24113038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of no-reflow/slow-flow phenomenon during rotational atherectomy--a prospective randomized study comparing intracoronary continuous infusion of verapamil and nicorandil.
    Matsuo H; Watanabe S; Watanabe T; Warita S; Kojima T; Hirose T; Iwama M; Ono K; Takahashi H; Segawa T; Minatoguchi S; Fujiwara H
    Am Heart J; 2007 Nov; 154(5):994.e1-6. PubMed ID: 17967610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiographic adverse events during percutaneous coronary intervention fail to predict creatine kinase-MB elevation.
    Blankenship JC; Islam MA; Wood GC; Iliadis EA
    Catheter Cardiovasc Interv; 2004 Sep; 63(1):31-41. PubMed ID: 15343564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of a heparin based rota-flush solution in patients undergoing rotational atherectomy.
    Whiteside HL; Ratanapo S; Sey A; Omar A; Kapoor D
    Cardiovasc Revasc Med; 2018; 19(3 Pt B):333-337. PubMed ID: 28988708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of rotational atherectomy in acute and stable coronary syndromes in the modern era.
    Doshi SN; Kini A; Kim MC; Payne N; Kamran M; Sherman W; Marmur JD; Sharma SK
    Am J Cardiol; 2003 Dec; 92(12):1404-8. PubMed ID: 14675574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alternative Rota-Flush Solution for Patients With Severe Coronary Artery Calcification who Undergo Rotational Atherectomy.
    Lee MS; Kim MH; Rha SW
    J Invasive Cardiol; 2017 Jan; 29(1):25-28. PubMed ID: 27315576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions.
    Abdelmeguid AE; Ellis SG; Sapp SK; Whitlow PL; Topol EJ
    Am Heart J; 1996 Jun; 131(6):1097-105. PubMed ID: 8644587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality.
    Hong MK; Mehran R; Dangas G; Mintz GS; Lansky AJ; Pichard AD; Kent KM; Satler LF; Stone GW; Leon MB
    Circulation; 1999 Dec; 100(24):2400-5. PubMed ID: 10595951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.